Opendata, web and dolomites

SUSPENCE

SUSPension ENvironment for CEll culture

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 SUSPENCE project word cloud

Explore the words cloud of the SUSPENCE project. It provides you a very rough idea of what is the project "SUSPENCE" about.

biotech    solution    months    damage    dimensional    unsustainable    commercialisation    explanatory    cells    morphological    total    drug    customers    scalability    moving    start    thrice    vitro    cell    bioreactor    basic    suffer    november    excellence    red    biological    financial    bioreactors    2d    deadline    requirement    intensive    labs    competing    mainly    damaging    amounts    maturity    revenues    36    parts    tank    microgravity    pilots    3rd    perfusion    labour    commercial    seal    2018    advantages    global    practically    74    protected    cellular    chamber    forecast    suspence    industrialization    september    release    disease    received    rotating    suspension    confirmed    patent    conventional    complexity    limitations    financially    solutions    expand    contamination    manual    market    monitoring    48    stirred    mechanism    operation    irr    firms    tests    commercialization    rotation    space    keeps    italian    large    manufacturing    size    innovative    capacity    technological    strategies    international    benefits    standardization    grow    culture    larger    interventions    dynamic    productivity   

Project "SUSPENCE" data sheet

The following table provides information about the project.

Coordinator
BIOCOM - BIOMEDICAL COMPONENTS SRL 

Organization address
address: PIAZZALE DELLE BELLE ARTI, 2
city: ROMA
postcode: 196
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Project website http://www.cellexpansiondevices.com/home.html
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-06-01   to  2019-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    BIOCOM - BIOMEDICAL COMPONENTS SRL IT (ROMA) coordinator 50˙000.00

Map

 Project objective

Large-scale production of cells is essential for basic research, disease modelling and drug testing. However, scalability and standardization in cellular manufacturing are still major challenges: when large numbers of cells are required, conventional two-dimensional (2D) culture strategies, mainly based on manual, space- and labour-intensive interventions, are practically and financially unsustainable. Dynamic suspension allows large-scale production of cells, but current solutions on the market suffer from limitations in terms of cells damaging and potential contamination (stirred tank bioreactors) or high cost and complexity (rotating bioreactors). The SUSPENCE solution is a microgravity perfusion bioreactor, a highly innovative technological system that keeps cells in suspension in the culture chamber, allowing them to grow and reach maturity in dynamic conditions with no rotation mechanism or moving parts. SUSPENCE benefits have been confirmed by explanatory morphological and biological tests carried out on an in vitro cell culture. SUSPENCE advantages on competing solutions are: less cell damage, more easy-to-use, increased productivity, better monitoring and control and reduced operation costs. The design of SUSPENCE bioreactor is protected by an international patent application. The target users are research labs and red-biotech firms and; the market size has been estimated in over 6.000 potential customers in EU. Commercialization will start on the Italian market in 20 months from the start of the project, after pre-commercial pilots and industrialization, to expand on the EU market in 36 months and to reach the global market in month 48, after release of larger capacity devices. Forecast revenues are 9 M€/year in the 3rd year of commercialisation. The total financial requirement amounts to about 2.5 M€, with an IRR of 74%. SUSPENCE received thrice the “Seal of Excellence” by European Commission in 2018 (deadline of May, September, November).

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SUSPENCE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SUSPENCE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

ECOBIOMASS (2019)

Achieving unique wines through an efficient production process

Read More  

COPI (2020)

Carbon Offset Plug-in

Read More  

Proteus 25 (2018)

Developing the world’s first food wrapping machine with organic film

Read More